➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Johnson and Johnson
McKesson
Express Scripts
Medtronic

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA AB v. HANMI USA, INC. (D.N.J. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ASTRAZENECA AB v. HANMI USA, INC. (D.N.J. 2011)

Docket   Start Trial Date Filed 2011-02-09
Court District Court, D. New Jersey Date Terminated 2013-06-03
Cause 35:145 Patent Infringement Assigned To Joel A. Pisano
Jury Demand None Referred To Tonianne J. Bongiovanni
Parties AKTIEBOLAGET HASSLE; ASTRAZENECA AB; ASTRAZENECA LP; HANMI FINE CHEMICAL CO., LTD; HANMI HOLDINGS CO., LTD.; HANMI PHARMACEUTICAL CO., LTD.; HANMI USA, INC.; KBI INC.; KBI-E INC.
Patents 6,143,771; 6,875,872
Attorneys ALLYN ZISSEL LITE; ARNOLD B. CALMANN; JEFFREY S. SOOS; JOHN EDMUND FLAHERTY; JONATHAN M.H. SHORT; MAYRA VELEZ TARANTINO; MICHAEL E. PATUNAS
Link to Docket External link to docket
Small Molecule Drugs cited in ASTRAZENECA AB v. HANMI USA, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ASTRAZENECA AB v. HANMI USA, INC. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-11-07 132 5,693,818 (HAN0038809-38816) 2 U.S. 6,875,872 (HAN0027430-27438) 3 MPEP 2111.03… 2011 3 June 2013 3:11-cv-00760 830 Patent None District Court, D. New Jersey External link to document
2011-12-30 167 . 10); • AstraZeneca’s U.S. Patent No. 6,143,771 (Ex. 3)3 uses the term “solid state” to …the ’504 patent specification. (D.I. 155, SOF ¶14.) AstraZeneca concedes that the ’504 patent does not…Claim 11). The ’771 patent, whose specification is identical to the ’504 patent, thus used “solid state…504 Patent with Ex. 3). By AstraZeneca’s own actions -- on the intrinsic record of the ’504 patent -- …As shown on the face of the ’771 patent, it is part of the ’504 patent's intrinsic record, since AstraZeneca External link to document
2011-12-30 170 .D 3 U.S. Patent No. 6,143,771 4 U.S. Patent No. 6,225,287 I declare… 2011 3 June 2013 3:11-cv-00760 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Johnson and Johnson
Harvard Business School
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.